The AIM-HI Accelerator Fund is pleased to announce that the 2024 Women’s Venture Competition’s first prize winner with distinction goes to HDAX Therapeutics led by its CEO and Co-Founder, Nabanita Nawar, Ph.D, and the Second Prize Winner goes to ARMA BIO,…
We are pleased to announce the winners of the 2024 BRACE Award Venture Competition: the First Prize goes to Concarlo Therapeutics, led by Founder and CEO Stacy Blain, Ph.D., and the Second Prize goes to Orphagen Pharmaceuticals, led by its…
The AIM-HI Accelerator Fund today announces Margaret Foti, PhD, MD (hc), Chief Executive Officer of the American Association for Cancer Research (AACR), is selected unanimously by the 2024 Blue Ribbon Selection Committee as the recipient of the 2024 Beacon Award…
Exciting News! The AIM-HI Accelerator Fund is thrilled to announce 4 Semi-Finalists competing in our Women's Venture Competition this year, selected from a pool of 58 applications submitted by women-led, early-stage oncology companies from 10 different countries! Congratulations to these…
Important Updates! This coming Monday will be the Big Day of our 2024 BRACE Award Venture Competition. We are thrilled to announce the 3 Semi-Finalists competing this year, selected from a pool of 41 applications submitted by early-stage oncology companies…
The 2024 AIM-HI Beacon Award for Women Leaders in Oncology is now open for nominations through May 31! The AIM-HI Accelerator Fund (AIM-HI) invites you to nominate an outstanding woman leader – in all health and life science sectors – who…
AIM-HI Accelerator Fundis proud to celebrate a significant milestone in the journey of one of its esteemed portfolio companies, Yiviva. A clinical-stage platform biotechnology company, Yiviva has entered into a Memorandum of Understanding (MOU) with AstraZeneca China, a multinational biopharmaceutical…
The AIM-HI Accelerator Fund (AIM-HI) is opening the 2024 Women's Venture Competition and BRACE Award Venture Competition to early-stage oncology companies worldwide seeking pre-seed, seed, and Series A investments. Women's Venture Competition Partnering with the National Foundation for Cancer Research,…
A critical juncture in medical research and drug discovery is known as the “valley of death” — a gap between academic innovations and their practical application in the real world. It’s a chasm where many promising breakthroughs languish due to…
Partnering with the National Foundation for Cancer Research, we successfully concluded the 2023 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship on Saturday, October 21, in person and live-streamed at the National Press Club in Washington, DC. We…
